Loren Clarke, M.D., is the Chief Medical Officer at DermTech, LLC, where he leads the company’s clinical and scientific efforts in implementing advanced molecular diagnostics for skin cancer. Dr. Clarke has been at the forefront of the company’s mission to revolutionize dermatological care through non-invasive genomic testing. A board-certified Pathologist and Dermatopathologist, Dr. Clarke brings extensive experience in clinical dermatopathology and molecular diagnostics. Prior to DermTech, he served as faculty at Penn State University’s Hershey Medical Center and contributed to the development of novel molecular diagnostics for melanoma at Myriad Genetics. Dr. Clarke has contributed significantly to the medical and scientific literature, authoring or co-authoring over 60 peer-reviewed publications, as well as numerous book chapters and a textbook on Dermatopathology.